{"id":"https://openalex.org/W2086201276","doi":"https://doi.org/10.2147/btt.s69606","title":"Antidrug antibodies against TNF-blocking agents: correlations between disease activity, hypersensitivity reactions, and different classes of immunoglobulins","display_name":"Antidrug antibodies against TNF-blocking agents: correlations between disease activity, hypersensitivity reactions, and different classes of immunoglobulins","publication_year":2015,"publication_date":"2015-02-01","ids":{"openalex":"https://openalex.org/W2086201276","doi":"https://doi.org/10.2147/btt.s69606","mag":"2086201276","pmid":"https://pubmed.ncbi.nlm.nih.gov/25733803","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4337417"},"language":"en","primary_location":{"id":"doi:10.2147/btt.s69606","doi":"https://doi.org/10.2147/btt.s69606","is_oa":true,"landing_page_url":"https://doi.org/10.2147/btt.s69606","pdf_url":"https://www.dovepress.com/getfile.php?fileID=23783","source":{"id":"https://openalex.org/S177732258","display_name":"Biologics","issn_l":"1177-5475","issn":["1177-5475","1177-5491"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biologics: Targets and Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/getfile.php?fileID=23783","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053922189","display_name":"Maurizio Benucci","orcid":"https://orcid.org/0000-0001-8180-6660","observed_orcids":["https://orcid.org/0000-0001-8180-6660"]},"institutions":[{"id":"https://openalex.org/I4210104099","display_name":"Nuovo Ospedale San Giovanni di Dio","ror":"https://ror.org/01c1ce922","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210104099"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Maurizio Benucci","raw_affiliation_strings":["Rheumatology Unit, Nuovo Ospedale S Giovanni di Dio, Florence, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rheumatology Unit, Nuovo Ospedale S Giovanni di Dio, Florence, Italy","institution_ids":["https://openalex.org/I4210104099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102827835","display_name":"Francesca Li Gobbi","orcid":"https://orcid.org/0000-0002-9318-0930","observed_orcids":["https://orcid.org/0000-0002-9318-0930"]},"institutions":[{"id":"https://openalex.org/I4210104099","display_name":"Nuovo Ospedale San Giovanni di Dio","ror":"https://ror.org/01c1ce922","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210104099"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Francesca Li Gobbi","raw_affiliation_strings":["Rheumatology Unit, Nuovo Ospedale S Giovanni di Dio, Florence, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rheumatology Unit, Nuovo Ospedale S Giovanni di Dio, Florence, Italy","institution_ids":["https://openalex.org/I4210104099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110635250","display_name":"Francesca Meacci","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104099","display_name":"Nuovo Ospedale San Giovanni di Dio","ror":"https://ror.org/01c1ce922","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210104099"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Francesca Meacci","raw_affiliation_strings":["Immunology and Allergology Laboratory Unit, Nuovo Ospedale S Giovanni di Dio, Florence, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunology and Allergology Laboratory Unit, Nuovo Ospedale S Giovanni di Dio, Florence, Italy","institution_ids":["https://openalex.org/I4210104099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074722507","display_name":"Mariangela Manfredi","orcid":"https://orcid.org/0000-0001-9242-2793","observed_orcids":["https://orcid.org/0000-0001-9242-2793"]},"institutions":[{"id":"https://openalex.org/I4210104099","display_name":"Nuovo Ospedale San Giovanni di Dio","ror":"https://ror.org/01c1ce922","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210104099"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Mariangela Manfredi","raw_affiliation_strings":["Immunology and Allergology Laboratory Unit, Nuovo Ospedale S Giovanni di Dio, Florence, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunology and Allergology Laboratory Unit, Nuovo Ospedale S Giovanni di Dio, Florence, Italy","institution_ids":["https://openalex.org/I4210104099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038039241","display_name":"Maria Giaele Infantino","orcid":"https://orcid.org/0000-0002-6200-4467","observed_orcids":["https://orcid.org/0000-0002-6200-4467"]},"institutions":[{"id":"https://openalex.org/I4210104099","display_name":"Nuovo Ospedale San Giovanni di Dio","ror":"https://ror.org/01c1ce922","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210104099"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Infantino","raw_affiliation_strings":["Immunology and Allergology Laboratory Unit, Nuovo Ospedale S Giovanni di Dio, Florence, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunology and Allergology Laboratory Unit, Nuovo Ospedale S Giovanni di Dio, Florence, Italy","institution_ids":["https://openalex.org/I4210104099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110888458","display_name":"Maurizio Giuseppe Severino","orcid":"https://orcid.org/0009-0004-1239-9562","observed_orcids":["https://orcid.org/0009-0004-1239-9562"]},"institutions":[{"id":"https://openalex.org/I4210104099","display_name":"Nuovo Ospedale San Giovanni di Dio","ror":"https://ror.org/01c1ce922","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210104099"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maurizio Severino","raw_affiliation_strings":["Allergy and Clinical Immunology Unit, Nuovo Ospedale S Giovanni di Dio, Florence, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Allergy and Clinical Immunology Unit, Nuovo Ospedale S Giovanni di Dio, Florence, Italy","institution_ids":["https://openalex.org/I4210104099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010984168","display_name":"Fabiola Atzeni","orcid":"https://orcid.org/0000-0002-9328-3075","observed_orcids":["https://orcid.org/0000-0002-9328-3075"]},"institutions":[{"id":"https://openalex.org/I4210113215","display_name":"IRCCS Ospedale Galeazzi - Sant'Ambrogio","ror":"https://ror.org/01vyrje42","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210113215","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Fabiola Atzeni","raw_affiliation_strings":["IRCCS Galeazzi Orthopedic Institute, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IRCCS Galeazzi Orthopedic Institute, Milan, Italy","institution_ids":["https://openalex.org/I4210113215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108088836","display_name":"Sergio Testi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104099","display_name":"Nuovo Ospedale San Giovanni di Dio","ror":"https://ror.org/01c1ce922","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210104099"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Sergio Testi","raw_affiliation_strings":["Allergy and Clinical Immunology Unit, Nuovo Ospedale S Giovanni di Dio, Florence, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Allergy and Clinical Immunology Unit, Nuovo Ospedale S Giovanni di Dio, Florence, Italy","institution_ids":["https://openalex.org/I4210104099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084430360","display_name":"Piercarlo Sarzi\u2010Puttini","orcid":"https://orcid.org/0000-0002-8673-5133","observed_orcids":["https://orcid.org/0000-0002-8673-5133"]},"institutions":[{"id":"https://openalex.org/I4210087773","display_name":"Luigi Sacco Hospital","ror":"https://ror.org/0025g8755","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210087773","https://openalex.org/I4210156709"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Piercarlo Sarzi-Puttini","raw_affiliation_strings":["Rheumatology Unit, L Sacco University Hospital, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rheumatology Unit, L Sacco University Hospital, Milan, Italy","institution_ids":["https://openalex.org/I4210087773"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089298165","display_name":"Cristian Ricci","orcid":"https://orcid.org/0000-0003-4113-8682","observed_orcids":["https://orcid.org/0000-0003-4113-8682"]},"institutions":[{"id":"https://openalex.org/I60668342","display_name":"University of Regensburg","ror":"https://ror.org/01eezs655","country_code":"DE","type":"education","lineage":["https://openalex.org/I60668342"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Cristian Ricci","raw_affiliation_strings":["Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany","institution_ids":["https://openalex.org/I60668342"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5053922189"],"corresponding_institution_ids":["https://openalex.org/I4210104099"],"apc_list":{"value":2320,"currency":"USD","value_usd":2320},"apc_paid":{"value":2320,"currency":"USD","value_usd":2320},"fwci":2.4324,"has_fulltext":true,"cited_by_count":25,"citation_normalized_percentile":{"value":0.87039861,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"9","issue":null,"first_page":"7","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.01590000092983246,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antidrug-antibodies","display_name":"antidrug antibodies","score":0.9860000014305115},{"id":"https://openalex.org/keywords/tnf-alpha-inhibitors","display_name":"TNF-alpha inhibitors","score":0.7200000286102295},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.9850000143051147},{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.7820000052452087},{"id":"https://openalex.org/keywords/etanercept","display_name":"etanercept","score":0.9860000014305115},{"id":"https://openalex.org/keywords/adalimumab","display_name":"adalimumab","score":1.0},{"id":"https://openalex.org/keywords/igg4-antibodies","display_name":"IgG4 antibodies","score":0.8830000162124634},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.6639999747276306},{"id":"https://openalex.org/keywords/hypersensitivity","display_name":"hypersensitivity","score":0.6850000023841858},{"id":"https://openalex.org/keywords/injection-site-reactions","display_name":"injection site reactions","score":0.9110000133514404},{"id":"https://openalex.org/keywords/disease-activity","display_name":"disease activity","score":0.6169999837875366},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.4830000102519989},{"id":"https://openalex.org/keywords/biologic-therapy-failure","display_name":"biologic failure","score":0.4869999885559082},{"id":"https://openalex.org/keywords/immunoglobulin-classes","display_name":"immunoglobulin classes","score":0.6029999852180481},{"id":"https://openalex.org/keywords/das28-remission","display_name":"DAS28 remission","score":0.621999979019165},{"id":"https://openalex.org/keywords/low-disease-activity","display_name":"low disease activity","score":0.5199999809265137}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8689191341400146},{"id":"https://openalex.org/C2780132546","wikidata":"https://www.wikidata.org/wiki/Q348260","display_name":"Adalimumab","level":3,"score":0.8106886148452759},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.7954393625259399},{"id":"https://openalex.org/C2777226972","wikidata":"https://www.wikidata.org/wiki/Q415343","display_name":"Etanercept","level":3,"score":0.6754878759384155},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.6656122207641602},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6036003232002258},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5725605487823486},{"id":"https://openalex.org/C198451711","wikidata":"https://www.wikidata.org/wiki/Q327657","display_name":"Rheumatology","level":2,"score":0.46923643350601196},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.38963770866394043},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32490670680999756}],"mesh":[],"locations_count":7,"locations":[{"id":"doi:10.2147/btt.s69606","doi":"https://doi.org/10.2147/btt.s69606","is_oa":true,"landing_page_url":"https://doi.org/10.2147/btt.s69606","pdf_url":"https://www.dovepress.com/getfile.php?fileID=23783","source":{"id":"https://openalex.org/S177732258","display_name":"Biologics","issn_l":"1177-5475","issn":["1177-5475","1177-5491"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biologics: Targets and Therapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3313019","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4337417","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:25733803","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25733803","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biologics : targets & therapy","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4337417","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4337417/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biologics","raw_type":"Text"},{"id":"pmh:oai:air.unimi.it:2434/643150","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2434/643150","pdf_url":null,"source":{"id":"https://openalex.org/S4306400516","display_name":"Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I189158943","host_organization_name":"University of Milan","host_organization_lineage":["https://openalex.org/I189158943"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:6713fa8d9a584df7b0b7a9a98680aafa","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/6713fa8d9a584df7b0b7a9a98680aafa","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Biologics: Targets & Therapy, Vol 2015, Iss default, Pp 7-12 (2015)","raw_type":"article"},{"id":"pmh:oai:dovepress.com/20499","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/antidrug-antibodies-against-tnf-blocking-agents-correlations-between-d-peer-reviewed-article-BTT","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.2147/btt.s69606","doi":"https://doi.org/10.2147/btt.s69606","is_oa":true,"landing_page_url":"https://doi.org/10.2147/btt.s69606","pdf_url":"https://www.dovepress.com/getfile.php?fileID=23783","source":{"id":"https://openalex.org/S177732258","display_name":"Biologics","issn_l":"1177-5475","issn":["1177-5475","1177-5491"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biologics: Targets and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2086201276.pdf","grobid_xml":"https://content.openalex.org/works/W2086201276.grobid-xml"},"referenced_works_count":21,"referenced_works":["https://openalex.org/W1524200221","https://openalex.org/W1594992446","https://openalex.org/W1641557591","https://openalex.org/W1979087618","https://openalex.org/W1986864699","https://openalex.org/W2008629972","https://openalex.org/W2014580981","https://openalex.org/W2017200913","https://openalex.org/W2025074151","https://openalex.org/W2088517709","https://openalex.org/W2090542053","https://openalex.org/W2101939433","https://openalex.org/W2110732019","https://openalex.org/W2119046820","https://openalex.org/W2122735365","https://openalex.org/W2129301243","https://openalex.org/W2133722333","https://openalex.org/W2135087799","https://openalex.org/W2149065814","https://openalex.org/W2187675918","https://openalex.org/W4245615739"],"related_works":["https://openalex.org/W2330851894","https://openalex.org/W2754727078","https://openalex.org/W2039933080","https://openalex.org/W2554350583","https://openalex.org/W2031785853","https://openalex.org/W2552004220","https://openalex.org/W2952679486","https://openalex.org/W2608850138","https://openalex.org/W2332518203","https://openalex.org/W4391522371"],"abstract_inverted_index":{"Although":[0],"anti-TNF":[1,92],"drugs":[2,101],"have":[3],"changed":[4],"the":[5,35,38,95,118,163,176,182,190,220,232,242,302,310,315,322,364],"clinical":[6],"course":[7],"of":[8,21,29,40,97,116,159,162,168,178,204,248,268,301,351],"rheumatoid":[9],"arthritis":[10],"(RA),":[11],"survival":[12],"rates":[13],"and":[14,49,71,109,150,166,216,228,235,238,258,278,293,319,328,343,371],"resistance-to-therapy":[15],"data":[16,335],"confirm":[17],"that":[18],"about":[19],"30%":[20],"RA":[22,54,64,361],"patients":[23,61,119,142,165,205,249,269,323,359],"fail":[24],"to":[25,33,51,66],"respond.":[26],"The":[27,141,187,202,246,266,349],"aim":[28],"this":[30],"study":[31,58],"was":[32,185],"evaluate":[34],"correlations":[36],"between":[37,287,340],"development":[39],"antidrug":[41,148,251,288],"antibodies,":[42,289,292],"specific":[43,290,352],"IgG4":[44,151,271,291,305,341,353,372],"antibodies":[45,149,152,252,272,354],"against":[46,153,355,373],"TNF":[47,154,356],"inhibitors,":[48],"resistance":[50],"therapy":[52],"in":[53,124,181,219,223,231,241,309,314,321,329,358],"patients.":[55],"This":[56],"retrospective":[57],"involved":[59],"129":[60],"with":[62,91,171,206,250,270,324,360,368],"established":[63],"na\u00efve":[65],"biological":[67],"agents":[68,93],"(98":[69],"females":[70],"32":[72],"males,":[73],"mean":[74],"age":[75],"56.7\u00b112.3":[76],"years,":[77,81],"disease":[78,130],"duration":[79],"6.3\u00b11.2":[80],"baseline":[82],"Disease":[83],"Activity":[84],"Score":[85],"[DAS]-28":[86],"3.2-5.6)":[87],"who":[88],"received":[89,103],"treatment":[90],"after":[94],"failure":[96],"conventional":[98],"disease-modifying":[99],"antirheumatic":[100],"(32":[102],"infliximab":[104],"[IFX],":[105],"58":[106],"etanercept":[107],"[ETN],":[108],"39":[110],"adalimumab":[111],"[ADA]).":[112],"After":[113,156],"6":[114],"months":[115],"treatment,":[117,160],"were":[120,143,193,296,307],"classified":[121],"as":[122],"being":[123],"remission":[125,224],"(DAS28":[126],"<2.6),":[127],"having":[128],"low":[129],"activity":[131],"(LDA;":[132],"DAS28":[133,139,326,345],"2.6-3.2),":[134],"or":[135],"not":[136,194,297],"responding":[137],"(NR:":[138],">3.2).":[140],"also":[144],"tested":[145],"for":[146,299],"serum":[147],"inhibitors.":[155],"24":[157],"weeks":[158],"38%":[161],"ETN-treated":[164],"28%":[167],"those":[169,330],"treated":[170],"ADA":[172,200,221,254,262,274,282,311],"had":[173],"injection-site":[174,369],"reactions;":[175],"rate":[177],"systemic":[179],"reactions":[180,295,370],"IFX":[183,243,259,279],"group":[184,244,312],"25%.":[186],"differences":[188],"among":[189],"three":[191,303],"groups":[192],"statistically":[195],"significant":[196,298],"(P=0.382;":[197],"ETN":[198,233,256,264,276,284,374],"versus":[199,263,283],"P=0.319).":[201],"percentages":[203,247,267],"adverse":[207,294,332],"events":[208],"stratified":[209],"by":[210],"drug":[211],"response":[212],"were:":[213,253,273],"LDA":[214,226,236],"8%":[215],"NR":[217,229,239],"18%":[218],"group;":[222,234],"3%,":[225],"22%,":[227],"10%":[230],"6%":[237],"16%":[240],"(P=0.051).":[245],"33.3%,":[255],"11.5%,":[257],"10.3%":[260],"(P=0.025;":[261],"P=0.015).":[265],"6%,":[275],"13%,":[277],"26%":[280],"(P=0.017;":[281],"P=0.437).":[285],"Associations":[286],"any":[300],"drugs.":[304],"levels":[306,342],"higher":[308,320],"than":[313],"other":[316],"two":[317],"groups,":[318],"worse":[325,344],"(NR)":[327],"experiencing":[331],"events.":[333],"These":[334],"suggest":[336],"a":[337,377],"possible":[338],"association":[339],"(r":[346],"(2)=5.8%,":[347],"P=0.011).":[348],"presence":[350],"blockers":[357],"might":[362],"affect":[363],"drugs'":[365],"activity.":[366],"Patients":[367],"may":[375],"show":[376],"decreased":[378],"response.":[379]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":6}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}